FOR AUTHORS
Search
Search Results
##search.searchResults.foundPlural##
-
The Global Implementation Guidelines Initiative: how to optimize cardio-renal-metabolic care worldwide
4933PDF: 834Appendix: 538HTML: 59 -
iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease
4589PDF: 4004Supplementary: 465Appendix: 399 -
SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
1567pdf: 422Supplementary Material: 103HTML: 245 -
What is new and what has changed in the 2026 Global Heart Failure Implementation Guidelines and why
571PDF: 435APPENDIX: 41HTML: 3 -
2026 iCARDIO Alliance Global Implementation Guidelines on Heart Failure
1867PDF: 1035APPENDIX: 66HTML: 3 -
Applicability of obesity clinical practice guidelines in low- and middle-income countries
1829PDF: 910Appendix: 326HTML: 59 -
2026 iCARDIO Alliance Global Implementation Guidelines on Ischemic Heart Disease
1295PDF: 659APPENDIX: 72HTML: 3 -
Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients
2549PDF: 1247SUPPLEMENTARY MATERIAL: 397GRAPHICAL ABSTRACT: 328HTML: 215 -
iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025
16229PDF: 9482Appendix: 1209 -
The effect of SGLT2 inhibitors on health status in patients with heart failure: a systematic review and meta-analysis
3811PDF: 900Conflict of interest: 389SUPPLEMENTARY MATERIAL: 343HTML: 126
1 - 20 of 20 items

